Blood Collection Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Collection Site (Venous {Needles and Syringes, Blood collection Tubes, Blood Bags, Others}, Capillary {Lancets, Micro-Container Tubes, Micro-Hematocrit Tubes, Warming Devices, Others}), By Application (Diagnostics, Treatment), By Method (Manual, Automated), By End-use (Hospitals, Blood Banks, Others), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 10.86 Billion
CAGR (2026-2031)	6.82%
Fastest Growing Segment	Hospitals
Largest Market	North America
Market Size (2031)	USD 16.13 Billion

Market Overview

The Global Blood Collection Market will grow from USD 10.86 Billion in 2025 to USD 16.13 Billion by 2031 at a 6.82% CAGR. The Global Blood Collection Market comprises specialized equipment such as needles, vacuum tubes, and blood bags used to extract blood for transfusion and diagnostics. Growth is primarily driven by the escalating burden of chronic conditions like cancer and a geriatric population requiring frequent medical interventions. Additionally, the rising incidence of trauma and expanding healthcare infrastructure in emerging economies bolster the demand for safe collection technologies.

However, the market faces impediments such as persistent supply chain volatility and donor shortages. According to the Association for the Advancement of Blood and Biotherapies, in 2025, sourcing type O negative blood to meet spot usage often required 48 hours or longer, highlighting critical logistical bottlenecks. These inefficiencies, combined with stringent regulatory compliance costs regarding donor safety, may constrain expansion in resource limited settings.

Key Market Drivers

The escalating prevalence of chronic and lifestyle-related diseases stands as a primary catalyst for the Global Blood Collection Market. Conditions such as cancer and diabetes necessitate frequent blood sampling for diagnostic confirmation, treatment monitoring, and disease management, thereby sustaining high volumes of consumable usage. For instance, according to the American Cancer Society, January 2025, in the 'Cancer Facts & Figures 2025', an estimated 2,041,910 new cancer cases are projected to occur in the United States, underscoring the critical need for reliable collection tools to support oncology workflows. This surge in disease burden compels healthcare providers to stockpile essential items like vacuum tubes and needles to maintain continuous diagnostic operations.

Simultaneously, the expansion of government initiatives promoting voluntary blood donation is actively reshaping market dynamics by stabilizing supply chains for transfusion procedures. National health organizations are increasingly investing in collection infrastructure to secure safe blood stocks for surgeries and emergency trauma cases. According to the World Health Organization, May 2025, in the 'Blood safety and availability' fact sheet, approximately 118.54 million blood donations are collected worldwide, reflecting the immense operational scale required of collection devices. This throughput translates into substantial commercial activity for major manufacturers. To illustrate this scale, according to Becton, Dickinson and Company, in 2025, the Life Sciences segment generated $1.3 billion in first-quarter revenue, driven significantly by volume strength in blood collection products.

Download Free Sample Report

Key Market Challenges

The challenging factor impeding the Global Blood Collection Market is the persistent issue of donor shortages. This factor directly hampers market growth by reducing the volume of collections, which is the primary determinant for the demand of consumables such as blood bags, needles, and vacuum tubes. Because the market is volume-driven, any decline in donor participation leads to an immediate contraction in the procurement of these single-use devices. Furthermore, chronic shortages create unpredictability in procurement cycles, forcing manufacturers to manage volatile order patterns rather than capitalizing on the steady demand increase typically expected from an aging population and expanding healthcare infrastructure.

This structural instability is highlighted by recent data indicating severe inventory deficits. According to America's Blood Centers, in February 2025, 25% of blood centers in the southern United States reported operating at critical inventory levels with a supply of one day or less. Such acute shortages demonstrate that despite the rising clinical necessity for blood products, the actual addressable market for collection equipment is constrained by the inability to secure sufficient donor turnout, directly stalling revenue expansion for market players.

Key Market Trends

The Expansion of Remote and At-Home Blood Collection Models is fundamentally altering the traditional phlebotomy landscape by decentralizing sample acquisition. This trend is underpinned by the adoption of microsampling devices that allow patients to collect capillary blood independently, thereby reducing the logistical burden on hospitals and improving compliance for decentralized clinical trials. The shift towards self-administration is not merely a convenience but a scalable operational model that manufacturers are actively commercializing to meet rising healthcare consumerism. The rapid uptake of these patient-centric solutions is demonstrated by significant commercial milestones. According to Tasso, Inc., October 2025, in the 'Tasso Celebrates Two Million Device Milestone' press release, the company announced it had sold a total of two million of its blood collection devices, reflecting the substantial market penetration of these remote sampling technologies.

Simultaneously, the market is experiencing a distinct Shift Toward Specialized Preservation Tubes for Liquid Biopsy and Genomics. As molecular diagnostics advance, there is a critical requirement for collection tubes containing proprietary preservatives that stabilize cell-free DNA (cfDNA) and prevent genomic contamination from white blood cell lysis during transport. This trend elevates the blood collection market from simple commodity consumables to high-value medical devices essential for oncology and non-invasive prenatal testing workflows. The demand for these sophisticated tubes is directly correlated with the exploding volume of genomic assays performed by diagnostic labs. For instance, according to Natera, Inc., November 2025, in the 'Natera Reports Third Quarter 2025 Financial Results' report, the company performed approximately 211,000 oncology tests in the third quarter alone, a 53.9% increase year-over-year, driving a parallel surge in the consumption of specialized stabilization tubes.

Segmental Insights

The Hospitals segment is currently identifying as the fastest-growing vertical within the Global Blood Collection Market, primarily driven by the escalating demand for immediate diagnostics in acute and emergency care settings. This accelerated expansion is fueled by the rising global volume of surgical procedures, trauma cases, and inpatient admissions for the management of chronic diseases, all of which necessitate frequent and precise blood sampling. Furthermore, the continuous modernization of healthcare infrastructure ensures that hospitals remain the central hub for complex high-volume testing. These facilities uniquely provide the controlled environment required to maintain strict adherence to clinical safety standards, thereby sustaining their rapid market development.

Regional Insights

North America maintains a leading position in the global blood collection market, driven primarily by the high prevalence of chronic diseases and a well-established healthcare infrastructure that supports frequent diagnostic testing. The region benefits significantly from the presence of major medical device manufacturers and favorable reimbursement policies that increase patient access to pathology services. Additionally, strict safety guidelines enforced by the U.S. Food and Drug Administration ensure the reliability of blood collection devices, fostering trust among healthcare providers. This regulatory stability, combined with rising awareness regarding blood donation, secures the region's dominant market status.

Recent Developments

• In March 2025, Magnolia Medical Technologies, Inc. released findings from a peer-reviewed study demonstrating the efficacy of its initial specimen diversion technology in reducing blood culture contamination. The research, conducted by a prominent academic medical center, indicated that using the Steripath Initial Specimen Diversion Device for blood draws from central venous catheters significantly improved diagnostic accuracy compared to standard methods. The study reported a substantial reduction in false-positive results and established that the technology could effectively identify true bloodstream infections. The company emphasized that these results supported the widespread adoption of engineered diversion solutions to enhance patient safety and lower hospital costs associated with sepsis misdiagnosis.
• In December 2024, Becton, Dickinson and Company (BD) and Babson Diagnostics expanded their commercial partnership to launch a capillary blood collection and testing solution for health systems and ambulatory care settings. This offering integrated the BD MiniDraw Capillary Blood Collection System with Babson’s proprietary automated sample handling and analysis ecosystem. The launch was designed to deliver high-quality diagnostic results from small-volume fingerstick samples, providing a less invasive alternative to traditional venipuncture. The companies positioned this development as a key method to improve patient access to diagnostic testing in non-acute environments, such as urgent care centers and physician offices, where phlebotomy services may be limited.
• In August 2024, Vitestro obtained CE marking for its autonomous blood drawing device, enabling its commercial release across the European Union. The company stated that this regulatory approval designated the system as the first autonomous phlebotomy technology to meet the rigorous standards of the European Medical Device Regulation. By utilizing a combination of artificial intelligence, ultrasound imaging, and robotics, the device performs blood draws independently, aiming to alleviate critical staffing shortages in clinical laboratories. Following this milestone, the company announced strategic plans for a limited market rollout at selected hospitals in the Netherlands and Denmark before scaling production for broader international adoption.
• In June 2024, Tasso, Inc. entered into a strategic collaboration with Lindus Health to integrate its remote blood collection technology into clinical research protocols. This partnership allowed Lindus Health to offer the patient-centric sampling devices as a standard option for trial sponsors, facilitating convenient at-home sample collection. The initiative aimed to reduce the logistical burden on participants by eliminating the need for travel to physical sites for phlebotomy, thereby potentially improving recruitment and retention rates in studies. The collaboration highlighted a significant shift toward decentralized clinical trials by utilizing devices that enable virtually painless, self-administered blood draws without professional assistance.

Key Market Players

• NIPRO Medical Corporation
• Abbott Laboratories Inc.
• Becton, Dickinson and Company
• Terumo Corporation
• Qiagen N.V
• Medtronic plc
• FL Medical s.r.l.
• SARSTEDT AG & Co. KG
• Greiner Holding AG
• Haemonetics Corporation

By Collection Site	By Application	By Method	By End-use	By Region
Venous {Needles and Syringes Blood collection Tubes Blood Bags Others} Capillary {Lancets Micro-Container Tubes Micro-Hematocrit Tubes Warming Devices Others}	Diagnostics Treatment	Manual Automated	Hospitals Blood Banks Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Blood Collection Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Blood Collection Market, By Collection Site:

• Venous {Needles and Syringes
• Blood collection Tubes
• Blood Bags
• Others}
• Capillary {Lancets
• Micro-Container Tubes
• Micro-Hematocrit Tubes
• Warming Devices
• Others}

• Blood Collection Market, By Application:

• Diagnostics
• Treatment

• Blood Collection Market, By Method:

• Manual
• Automated

• Blood Collection Market, By End-use:

• Hospitals
• Blood Banks
• Others

• Blood Collection Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE